12th Jun, 2025 ASX-listed Bioxyne has upgraded its FY2025 revenue guidance from $25 million to $28 million, citing strong […] The post Bioxyne upgrades FY25 revenue forecast to $28m appeared first on Cannabiz. Continue reading... Click to expand...
ASX-listed Bioxyne has upgraded its FY2025 revenue guidance from $25 million to $28 million, citing strong […] The post Bioxyne upgrades FY25 revenue forecast to $28m appeared first on Cannabiz. Continue reading...